価格表

在庫・価格 : 2024年06月08日 14時51分 現在

商品名 商品コード メーカー 包装 価格 在庫 リスト
Flk-1/Fc Chimera, Mouse, Recombinant <VEGF Receptor 2>
データシート
443-KD-050 RSDアールアンドディー システムス
R&D Systems, Inc.
50 μg ¥95,000
(未発注)
追加

在庫・価格 : 2024年06月08日 14時51分 現在

Flk-1/Fc Chimera, Mouse, Recombinant <VEGF Receptor 2>

  • 商品コード:443-KD-050
  • メーカー:RSD
  • 包装:50μg
  • 価格: ¥95,000
  • 在庫:無(未発注)
使用文献
No. 文献情報 備考 参照
1 Raskopf E et al. Effective angiostatic treatment in a murine metastatic and orthotopic hepatoma model. Hepatology 2005 Jun;41(6):1233-40
Raskopf E et al
2005/01/01
Application: Western Blot, Sample Type: Serum PubMed
2 Schmitz V et al. Increased VEGF levels induced by anti-VEGF treatment are independent of tumor burden in colorectal carcinomas in mice. Gene Ther. 2006 Aug;13(16):1198-205
Schmitz V et al
2006/01/01
Species: Mouse, Application: Western Blot Control, Serum PubMed
3 Getmanova EV et al. Antagonists to human and mouse vascular endothelial growth factor receptor 2 generated by directed protein evolution in vitro. Chem. Biol. 2006 May;13(5):549-56
Getmanova EV et al
2006/01/01
Species: Human, Application: Biacore binding study, Sample type: recombinant VEGF PubMed
4 Wada T et al. Vascular endothelial growth factor directly inhibits primitive neural stem cell survival but promotes definitive neural stem cell survival. J. Neurosci. 2006 Jun;26(25):6803-12
Wada T et al
2006/01/01
Species: Mouse, Application: Bioassay, Sample type: Whole Cells PubMed
5 Ponticelli S et al. Modulation of angiogenesis by a tetrameric tripeptide that antagonizes vascular endothelial growth factor receptor 1. J. Biol. Chem. 2008 Dec;283(49):34250-9
Ponticelli S et al
2008/01/01
Application: Bioassay, Sample Type: Other: Tetrameric 4-23-5 Peptide PubMed
6 Wuest TR et al. VEGF-A expression by HSV-1-infected cells drives corneal lymphangiogenesis. J. Exp. Med. 2010 Jan;207(1):101-15
Wuest TR et al
2010/01/01
Application: In Vivo, Sample Type: In Vivo PubMed
7 Fleetwood F et al. Simultaneous targeting of two ligand-binding sites on VEGFR2 using biparatopic Affibody molecules results in dramatically improved affinity. Sci Rep 2014;4:7518
Fleetwood F et al
2014/01/01
Application: Bioassay, Sample Type: affibody molecule PubMed
  • No.: 1
  • 文献情報:
    Raskopf E et al. Effective angiostatic treatment in a murine metastatic and orthotopic hepatoma model. Hepatology 2005 Jun;41(6):1233-40
    Raskopf E et al
    2005/01/01
  • 備考:
    Application: Western Blot, Sample Type: Serum
  • 参照:
    PubMed
  • No.: 2
  • 文献情報:
    Schmitz V et al. Increased VEGF levels induced by anti-VEGF treatment are independent of tumor burden in colorectal carcinomas in mice. Gene Ther. 2006 Aug;13(16):1198-205
    Schmitz V et al
    2006/01/01
  • 備考:
    Species: Mouse, Application: Western Blot Control, Serum
  • 参照:
    PubMed
  • No.: 3
  • 文献情報:
    Getmanova EV et al. Antagonists to human and mouse vascular endothelial growth factor receptor 2 generated by directed protein evolution in vitro. Chem. Biol. 2006 May;13(5):549-56
    Getmanova EV et al
    2006/01/01
  • 備考:
    Species: Human, Application: Biacore binding study, Sample type: recombinant VEGF
  • 参照:
    PubMed
  • No.: 4
  • 文献情報:
    Wada T et al. Vascular endothelial growth factor directly inhibits primitive neural stem cell survival but promotes definitive neural stem cell survival. J. Neurosci. 2006 Jun;26(25):6803-12
    Wada T et al
    2006/01/01
  • 備考:
    Species: Mouse, Application: Bioassay, Sample type: Whole Cells
  • 参照:
    PubMed
  • No.: 5
  • 文献情報:
    Ponticelli S et al. Modulation of angiogenesis by a tetrameric tripeptide that antagonizes vascular endothelial growth factor receptor 1. J. Biol. Chem. 2008 Dec;283(49):34250-9
    Ponticelli S et al
    2008/01/01
  • 備考:
    Application: Bioassay, Sample Type: Other: Tetrameric 4-23-5 Peptide
  • 参照:
    PubMed
  • No.: 6
  • 文献情報:
    Wuest TR et al. VEGF-A expression by HSV-1-infected cells drives corneal lymphangiogenesis. J. Exp. Med. 2010 Jan;207(1):101-15
    Wuest TR et al
    2010/01/01
  • 備考:
    Application: In Vivo, Sample Type: In Vivo
  • 参照:
    PubMed
  • No.: 7
  • 文献情報:
    Fleetwood F et al. Simultaneous targeting of two ligand-binding sites on VEGFR2 using biparatopic Affibody molecules results in dramatically improved affinity. Sci Rep 2014;4:7518
    Fleetwood F et al
    2014/01/01
  • 備考:
    Application: Bioassay, Sample Type: affibody molecule
  • 参照:
    PubMed